Literature DB >> 11154131

Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease--single center comparison of four different assays.

A B Federici, M T Canciani, I Forza, G Cozzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11154131

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  13 in total

1.  Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease.

Authors:  V H Flood; J C Gill; P A Christopherson; J S Wren; K D Friedman; S L Haberichter; R G Hoffmann; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

2.  Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.

Authors: 
Journal:  P T       Date:  2010-01

Review 3.  Treatment of von Willebrand disease with FVIII/VWF concentrates.

Authors:  Giancarlo Castaman
Journal:  Blood Transfus       Date:  2011-05       Impact factor: 3.443

Review 4.  Diagnostic approach to von Willebrand disease.

Authors:  Christopher Ng; David G Motto; Jorge Di Paola
Journal:  Blood       Date:  2015-02-23       Impact factor: 22.113

Review 5.  von Willebrand's disease diagnosis and laboratory issues.

Authors:  G Castaman; R R Montgomery; S S Meschengieser; S L Haberichter; A I Woods; M A Lazzari
Journal:  Haemophilia       Date:  2010-07       Impact factor: 4.287

Review 6.  Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.

Authors:  Veronica H Flood
Journal:  Semin Thromb Hemost       Date:  2013-12-12       Impact factor: 4.180

7.  New advances in the diagnosis of von Willebrand disease.

Authors:  Ruchika Sharma; Sandra L Haberichter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

8.  Collagen binding provides a sensitive screen for variant von Willebrand disease.

Authors:  Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Pamela A Christopherson; Paula M Jacobi; Raymond G Hoffmann; Robert R Montgomery; Sandra L Haberichter
Journal:  Clin Chem       Date:  2013-01-22       Impact factor: 8.327

9.  Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and α2β1-mediated collagen binding in thrombus formation.

Authors:  Yasuaki Shida; Natalia Rydz; David Stegner; Christine Brown; Jeffrey Mewburn; Kate Sponagle; Ozge Danisment; Bredon Crawford; Barbara Vidal; Carol A Hegadorn; Cynthia M Pruss; Bernhard Nieswandt; David Lillicrap
Journal:  Blood       Date:  2014-07-22       Impact factor: 22.113

10.  Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.

Authors:  Richard D Starke; Koralia E Paschalaki; Clare E F Dyer; Kimberly J Harrison-Lavoie; Jacqueline A Cutler; Thomas A J McKinnon; Carolyn M Millar; Daniel F Cutler; Mike A Laffan; Anna M Randi
Journal:  Blood       Date:  2013-01-25       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.